Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Qifangfeixian Granules in the Treatment of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD) [Phase 2, Phase 3]

View source ↗

Summary

This is a randomized, double-blind, placebo-controlled multicenter study evaluating the efficacy and safety of Qifangfeixian Granules for connective tissue dise…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Connective Tissue Disease-associated Interstitial Lung Disease
• Interstitial Lung Disease

Drugs mentioned

• Qifangfeixian Granules

Snippet

Sponsor: Huilan Zhang | Conditions: Interstitial Lung Disease, Qifangfeixian Granules | Phase 2, Phase 3 | Status: RECRUITING